WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
Open this folder and view contentsParasitic infections
Open this folder and view contentsInsect and arachnid bites and stings
Open this folder and view contentsSuperficial fungal infections
Open this folder and view contentsSubcutaneous fungal infections
Open this folder and view contentsBacterial infections
Open this folder and view contentsViral infections
Open this folder and view contentsEczematous diseases
Open this folder and view contentsScaling diseases
Open this folder and view contentsPapulosquamous diseases
View the documentCutaneous reactions to drugs
Open this folder and view contentsPigmentary disorders
Open this folder and view contentsPremalignant lesions and malignant tumours
Open this folder and view contentsPhotodermatoses
Open this folder and view contentsBullous dermatoses
View the documentAlopecia areata
View the documentUrticaria
Open this folder and view contentsConditions common in children
View the documentAcne vulgaris
View the documentPruritus
View the documentTropical ulcers
Open this folder and view contentsAntimicrobial drugs
Close this folderAntifugal drugs
View the documentAmphotericin B
View the documentBenzoic acid + salicylic acid (Whitfield’s ointment)
View the documentClotrimazole
View the documentEconazole
View the documentFluconazole
View the documentFlucytosine
View the documentGriseofulvin
View the documentItraconazole
View the documentKetoconazole
View the documentMiconazole
View the documentNystatin
View the documentPotassium iodide
View the documentSelenium sulfide
View the documentSodium thiosulfate
View the documentTerbinafine
Open this folder and view contentsAntiseptic agents
Open this folder and view contentsKeratoplastic and keratolytic agents
Open this folder and view contentsScabicides and pediculicides
Open this folder and view contentsAnti-inflammatory and antipruritic drugs1
Open this folder and view contentsAntiallergics and drugs used in anaphylaxis
Open this folder and view contentsUltraviolet radiation-blocking agents (sunscreens)
Open this folder and view contentsMiscellaneous drugs
Open this folder and view contentsAnnex
View the documentSelected WHO Publications of Related Interest
View the documentBack cover
 

Selenium sulfide

Detergent-based suspension, 2.5%

General information

Selenium sulfide is an anti-infective agent with antibacterial and mild anti-fungal activity.

Clinical information

Uses

Treatment of pityriasis (tinea) versicolor and seborrhoeic dermatitis.

Dosage and administration

All doses are suitable for adults and children over 2 years.

Pityriasis versicolor:

A thin coating of undiluted suspension should be applied at bedtime to the trunk, groin, upper limbs and axillae and rinsed off after 5-15 minutes. Treatment should be repeated after 3 and 6 days.

Seborrhoeic dermatitis:

5-10 ml of the suspension is massaged into the wet scalp and left for 2-3 minutes before rinsing off. Treatment should be repeated twice weekly for 2 weeks.

Contraindications

• Known hypersensitivity to selenium sulfide.
• Age under 2 years.

Precautions

Treatment should be discontinued if cutaneous sensitization occurs.

Selenium sulfide suspension should not be applied to damaged skin because of the risk of systemic toxicity. Contact with the eyes should also be avoided.

Use in pregnancy

Safe use in pregnancy has not been established. Treatment is best deferred until after delivery.

Adverse effects

Prolonged contact with the skin may cause local irritation.

Topical application to damaged skin can cause systemic toxicity, characterized by tremors, weakness, lethargy, pain in the lower abdomen and occasional vomiting. These symptoms usually resolve within 10 days of discontinuing treatment.

Storage

Selenium sulfide suspension should be stored in tightly closed containers in a cool place.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018